Related Experiment Videos

Metastatic renal cell carcinoma to the nose and paranasal sinuses

R Simo1, A J Sykes, S P Hargreaves

  • 1University Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Lewisham, Lewisham High Street, London SE13 6LR, United Kingdom.

Head & Neck
|September 26, 2000
PubMed
Abstract

Insights

Metastatic renal cell carcinoma (RCC) to the nose and sinuses causes severe symptoms. Radiotherapy effectively controls these nasal symptoms, offering significant relief for patients with this rare cancer spread.

Area of Science:

  • Oncology
  • Otorhinolaryngology
  • Radiotherapy

Background:

  • Renal cell carcinoma (RCC) accounts for 3% of all malignancies.
  • Metastases of RCC to the head and neck are uncommon.
  • This study focuses on RCC metastasis to the nose and sinuses.

Purpose of the Study:

  • To analyze the clinical presentation of nasal and sinus metastases from RCC.
  • To evaluate radiologic features, treatment, and outcomes.
  • To understand the management of this rare metastatic pattern.

Main Methods:

  • Retrospective review of 6 patients with RCC and nasal metastasis.
  • Data collected over 8 years at Christie Hospital, Manchester.
  • Inclusion of clinical, radiological, and treatment data.

Main Results:

  • Patients presented with epistaxis, nasal obstruction, and crusting.
  • Three patients had orbital involvement.
  • Histology confirmed RCC metastases; radiotherapy achieved symptomatic control.

Conclusions:

  • Metastatic RCC to the nose and paranasal sinuses is rare but causes significant symptoms.
  • Local radiotherapy provides excellent symptomatic control for these metastases.

Related Concept Videos